EF Hutton Maintains Buy on CytoSorbents, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
EF Hutton analyst Jason Kolbert maintains a Buy rating on CytoSorbents (NASDAQ:CTSO) with a $10 price target.
August 14, 2024 | 4:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton analyst Jason Kolbert maintains a Buy rating on CytoSorbents with a $10 price target.
The reaffirmation of a Buy rating and a $10 price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100